Complement mediated renal inflammation induced by donor brain death: Role of renal C5a-C5aR interaction

American Journal of Transplantation

Volumn 13, Issue 4, 2013, Pages 875-882

  Van Werkhoven, M B ^a   Damman, J ^a   Van Dijk, M C R F ^a,b   Daha, M R ^a   De Jong, I J ^a   Leliveld, A ^a   Krikke, C ^a   Leuvenink, H G ^a   Van Goor, H ^a   Van Son, W J ^a   Olinga, P ^c   Hillebrands, J L ^a   Seelen, M A J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

C5aR; Complement; donor brain death; renal transplantation

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; ARTICLE; BRAIN DEAD DONOR; CADAVER DONOR; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY PARENCHYMA; KIDNEY SLICE; LIVING DONOR; MALE; NEPHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BIOPSY; BRAIN DEATH; COMPLEMENT C5A; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; KIDNEY; LIVING DONORS; MALE; MIDDLE AGED; RECEPTORS, COMPLEMENT;

EID: 84875701958     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12130     Document Type: Article

References (33)

1. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S,. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333-336.
2. Kusaka M, Pratschke J, Wilhelm MJ, et al. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation 2000; 69: 405-410. (Pubitemid 30118123)
3. Pratschke J, Wilhelm MJ, Laskowski I, et al. Influence of donor brain death on chronic rejection of renal transplants in rats. J Am Soc Nephrol 2001; 12: 2474-2481. (Pubitemid 33021126)
4. Pratschke J, Wilhelm MJ, Kusaka M, et al. Accelerated rejection of renal allografts from brain-dead donors. Ann Surg 2000; 232: 263-271. (Pubitemid 30616728)
5. Lopau K, Mark J, Schramm L, Heidbreder E, Wanner C,. Hormonal changes in brain death and immune activation in the donor. Transpl Int 2000; 13 Suppl 1: S282-S285.
6. Nijboer WN, Schuurs TA, van der Hoeven JA, et al. Effect of brain death on gene expression and tissue activation in human donor kidneys. Transplantation 2004; 78: 978-986. (Pubitemid 39391858)
7. Amado JA, Lopez-Espadas F, Vazquez-Barquero A, et al. Blood levels of cytokines in brain-dead patients: Relationship with circulating hormones and acute-phase reactants. Metabolism 1995; 44: 812-816.
8. van der Hoeven JA, Molema G, Ter Horst GJ, et al. Relationship between duration of brain death and hemodynamic (in)stability on progressive dysfunction and increased immunologic activation of donor kidneys. Kidney Int 2003; 64: 1874-1882. (Pubitemid 37323719)
9. van der Hoeven JA, Ploeg RJ, Postema F, et al. Induction of organ dysfunction and up-regulation of inflammatory markers in the liver and kidneys of hypotensive brain dead rats: A model to study marginal organ donors. Transplantation 1999; 68: 1884-1890. (Pubitemid 30027342)
10. Naesens M, Li L, Ying L, et al. Expression of complement components differs between kidney allografts from living and deceased donors. J Am Soc Nephrol; 20: 1839-1851.
11. Damman J, Nijboer WN, Schuurs TA, et al. Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation. Nephrol Dial Transplant 2011; 26: 2345-2354.
12. Damman J, Hoeger S, Boneschansker L, et al. Targeting complement activation in brain-dead donors improves renal function after transplantation. Transpl Immunol 2011; 24: 233-237.
13. Walport MJ,. Complement. First of two parts. N Engl J Med 2001; 344: 1058-1066.
14. Damman J, Seelen MA, Moers C, et al. Systemic complement activation in deceased donors is associated with acute rejection after renal transplantation in the recipient. Transplantation 2011; 92: 163-169.
15. van Werkhoven MB, Damman J, Daha MR, et al. Novel insights in localization and expression levels of C5aR and C5L2 under native and post-transplant conditions in the kidney. Mol Immunol 2013 53: 237-245.
16. Olinga P, Groen K, Hof IH, et al. Comparison of five incubation systems for rat liver slices using functional and viability parameters. J Pharmacol Toxicol Methods 1997; 38: 59-69. (Pubitemid 27515918)
17. van de Bovenkamp M, Groothuis GM, Meijer DK, Slooff MJ, Olinga P,. Human liver slices as an in vitro model to study toxicity-induced hepatic stellate cell activation in a multicellular milieu. Chem Biol Interact 2006; 162: 62-69. (Pubitemid 44080167)
18. de Graaf IA, de Kanter R, de Jager MH, et al. Empirical validation of a rat in vitro organ slice model as a tool for in vivo clearance prediction. Drug Metab Dispos 2006; 34: 591-599.
19. de Graaf IA, Draaisma AL, Schoeman O, Fahy GM, Groothuis GM, Koster HJ,. Cryopreservation of rat precision-cut liver and kidney slices by rapid freezing and vitrification. Cryobiology 2007; 54: 1-12. (Pubitemid 46282696)
20. Graaf IA, Groothuis GM, Olinga P,. Precision-cut tissue slices as a tool to predict metabolism of novel drugs. Expert Opin Drug Metab Toxicol 2007; 3: 879-898. (Pubitemid 350285341)
21. van de Bovenkamp M, Groothuis GM, Meijer DK, Olinga P,. Liver slices as a model to study fibrogenesis and test the effects of anti-fibrotic drugs on fibrogenic cells in human liver. Toxicol In Vitro 2008; 22: 771-778.
22. de Graaf IA, Olinga P, de Jager MH, et al. Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies. Nat Protoc 2010; 5: 1540-1551.
23. Rabiet MJ, Huet E, Boulay F,. The N-formyl peptide receptors and the anaphylatoxin C5a receptors: An overview. Biochimie 2007; 89: 1089-1106. (Pubitemid 47260646)
24. Monk PN, Scola AM, Madala P, Fairlie DP,. Function, structure and therapeutic potential of complement C5a receptors. Br J Pharmacol 2007; 152: 429-448. (Pubitemid 47585036)
25. Lee H, Whitfeld PL, Mackay CR,. Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2. Immunol Cell Biol 2008; 86: 153-160. (Pubitemid 351301771)
26. De Vries B, Kohl J, Leclercq WK, et al. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J Immunol 2003; 170: 3883-3889. (Pubitemid 36359260)
27. De Vries B, Matthijsen RA, Wolfs TG, Van Bijnen AA, Heeringa P, Buurman WA,. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: Inhibition of late apoptosis and inflammation. Transplantation 2003; 75: 375-382. (Pubitemid 36222966)
28. Arumugam TV, Shiels IA, Strachan AJ, Abbenante G, Fairlie DP, Taylor SM,. A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. Kidney Int 2003; 63: 134-142. (Pubitemid 35463914)
29. Zheng X, Zhang X, Feng B, et al. Gene silencing of complement C5a receptor using siRNA for preventing ischemia/reperfusion injury. Am J Pathol 2008; 173: 973-980.
30. Gueler F, Rong S, Gwinner W, et al. Complement 5a receptor inhibition improves renal allograft survival. J Am Soc Nephrol 2008; 19: 2302-2312.
31. Lewis AG, Kohl G, Ma Q, Devarajan P, Kohl J,. Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival. Clin Exp Immunol 2008; 153: 117-126. (Pubitemid 351809344)
32. Li Q, Peng Q, Xing G, et al. Deficiency of C5aR prolongs renal allograft survival. J Am Soc Nephrol 2010; 21: 1344-1353.
33. Stegall MD, Diwan T, Raghavaiah S, et al. Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients. Am J Transplant 2011; 11: 2405-2413.